Vitamin D deficiency: Appropriate replenishment therapies and the effects of vitamin D toxicity

Consultant Pharmacist

Volumn 25, Issue 3, 2010, Pages 171-177

  Carlton, Sean ^a   Clopton, David ^b   Cappuzzo, Kimberly A ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b FEDERAL BUREAU OF PRISONS   (United States)

^c Metabolic Bone Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; ERGOCALCIFEROL; FUROSEMIDE; LEVOTHYROXINE; LISINOPRIL; METOPROLOL; MONTELUKAST; SIMVASTATIN; VITAMIN D; WARFARIN;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DECREASED APPETITE; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; PHYSICIAN; PRESCRIPTION; SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

AGED, 80 AND OVER; APPETITE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOCALCIFEROLS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; VITAMIN D DEFICIENCY; VITAMINS; WEIGHT LOSS;

EID: 77950674557     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2010.171     Document Type: Article

References (47)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
2. Cherniack ER Levis S, Troen BR. Hypovitaminosis D: a stealthy epidemic that requires treatment. Geriatrics 2008;63:24-30.
3. Peacock M. Effects of calcium and vitamin D insufficiency on the skeleton. Osteoporos Int 1998;8 Suppl:45-51.
4. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13-19.
5. Bouillon R, Carmeliet G, Dad E et al. Vitamin D metabolism and action. Osteoporos Int 1998;Suppl 8:13-9.
6. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrin Diabet 2002;9:87-98.
7. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-8.
8. Schwakenberg G. Not enough vitamin D: health consequences for Canadians. Can Fam Physician 2007;53:841-54.
9. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008:87 Suppl: 1080-6.
10. Bischoff-Ferrari HA, Borchers M, Gudat F et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004;19:265-9.
11. Chel V, Wijnhoven HA, Smit JH et al. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008;19:663-71.
12. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr 2006;136:1123-5.
13. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116:634-9.
14. Bischoff-Ferrari HA. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007;18:401-7.
15. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exper Med Biol 2008;624:55-71.
16. Bischoff-Ferrari HA, Dietrich T, Orav EJ et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or=60 y. Am J Clin Nutr 2004;80:752-8.
17. Fosnight SM, Zafirau WJ, Hazelett SE. vitamin D supplementation to prevent falls in the elderly: evidence and practical considerations. Pharmacotherapy 2008;28:225-34.
18. Broe KE, Chen TC, Weinberg J et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234-9.
19. WangTJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
20. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168:1340-9.
21. Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008; 11:7-12.
22. Lister T. Should long-term care residents be supplemented with vitamin D? Can J Diet Pract Res 2008;69:28-31.
23. Bischoff-Ferrari HA, WillettWC, Wong JB et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
24. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73-8.
25. Dawson-Hughes B, Heaney RP, Holick MF et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6.
26. Hollis BW Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-22.
27. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42 4 Suppl 3:1-201.
28. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-91.
29. Trang HM, Cole DE, Rubin LA et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:854-8.
30. Houghton LA, Vieth R.The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006;84:694-7.
31. Holick MF, Biancuzzo RM, Chen TC et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008;93:677-81, .
32. Aloia JF, Patel M, Dimaano R et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008;87:1952-8.
33. DiamondTH, Ho KW, Rohl PG et al. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005; 183:10-2.
34. Lyles KW, Colon-Emeric C. Treating vitamin D deficiency in long-term care: it should be done yesterday, but how? J Am Med Dir Assoc 2004;5:416-7.
35. Przybelski R, Agrawal S, Krueger D et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008;19:1621-8.
36. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469. (Pubitemid 36269626)
37. Institute of Medicine of the National Academies, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
38. Institute of Medicine of the National Academies, Food and Nutrition Board. Dietary reference intakes for vitamin D and calcium. Available at http://www.iom.edu/Activities/Nutrition/DRIvitDCalcium.aspx. Accessed February 27, 2010.
39. National Osteoporosis Foundation (NOF). Prevention: vitamin D. 2008. Available at http://www.nof.org/prevention/vitaminD.htm. Accessed August 7, 2008.
40. Bischoff-Ferrari HA, Giovannucci E, WillettWC et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. (Pubitemid 44699167)
41. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr 2004;80(Suppl 6):1763S-6S.
42. Hathcock JN, Shao A, Vieth R et al. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18. (Pubitemid 46067609)
43. Vitamin D in DRUGDEX® System [intranet database]. Version 5.1. Greenwood Village, CO:Thomson Healthcare. Accessed August 15, 2008.
44. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000;6:442-7.
45. Gertner JM, Domenech M. 25-hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. J Clin Pathol 1977;30:144-50. (Pubitemid 8037568)
46. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56. (Pubitemid 29205056)
47. Agus ZA, Drezner MK. Causes of vitamin D deficiency and resistance. In Basow DS, ed. UpToDate. Waltham, MA: UpToDate; 2008.